https://www.prnewswire.co.uk/news-releases/takeda-receives-european-commission-marketing-authorisation-for-entyvior-vedolizumab-for-the-treatment-of-ulcerative-colitis-and-crohns-disease-260767811.html
/PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the...
european commissionmarketing authorisationtakedareceivesentyvio
https://www.medicines.org.uk/emc/product/5442/pil
Entyvio 300 mg powder for concentrate for solution for infusion - Patient Information Leaflet (PIL) by Takeda UK Ltd
entyviomgpowderconcentratesolution